Those results illustrate the lack of specificity of CA9 gene expression to identify CTC in RCC blood samples, as CAIX can also be expressed in hypoxic or necrotic tissues regardless of their tumor origin. The gene discussed is CA9; the disease is renal cell carcinoma.